Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Smith, Jodi
NCT04239391: Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)	Recruiting	3	150	US	Triferic, FPC	Rockwell Medical Technologies, Inc.	End Stage Renal Disease	08/23	11/23
NCT03763643 / 2013-002651-15: PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant	Recruiting	1	60	US	Rituximab, Plasmapheresis	University of Minnesota, United States Department of Defense	Focal Segmental Glomerulosclerosis	08/25	12/26
Byck, Dann
No trials found